Cancer/Tumor Profiling Market Key Findings by 2031
:
Tumor profiling services use a variety of methods for the examination of patient's tumor. Some utilize next generation DNA sequencing or RNA sequencing, while others analyze protein expression. Multiple technologies are used to provide very specific information about the molecular and genetic makeup of the tumor. Tumor profiling companies utilize various methods to examine the biopsy sample, and return information about the genes altered in the cancer cells.
MARKET SCOPE
The "Cancer/tumor profiling market to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cancer/tumor profiling market with detailed market segmentation by of Product, Technology, Animal type, End Users. The cancer/tumor profiling market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cancer/tumor profiling market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- n the basis of product, the market is segmented into Instruments and Consumables.
- n the basis of technology, the market is segmented into Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis and Others.
- n the basis of animal type, the market is segmented into Livestock animals, Companion, Animal.
- n the basis of end User, the market is segmented into Veterinary Hospitals and Clinics, Homecare Settings, Reference Laboratories and Research Institutes & Universities.
MARKET DYNAMICS
Drivers:
- Oncologists are increasingly using cancer profiling methods to diagnose and treat malignancies, as well as predict response to targeted therapy. Furthermore, an increase in the use of cancer biomarkers for tumour profiling, an increase in cancer incidence around the world, and an increase in the use of next-generation sequencing techniques for cancer profiling all contribute to the market's growth.
Restraints
The market's growth is hampered by high monetary investments in biomarker research and a shortage of experienced specialists or oncologists that specialized in tumor profiling.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cancer/tumor profiling market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer/tumor profiling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cancer/tumor profiling market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cancer/tumor profiling market in these regions.
IMPACT OF COVID-19 ON CANCER/TUMOR PROFILING MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the cancer/tumor profiling market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cancer/tumor profiling market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer/tumor profiling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cancer/tumor profiling market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cancer/tumor profiling market in these regions.
IMPACT OF COVID-19 ON CANCER/TUMOR PROFILING MARKET:
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. The global impacts of the COVID-19 are already starting to be felt, and will significantly affect the cancer/tumor profiling market in 2021.Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the cancer/tumor profiling market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cancer/tumor profiling market are anticipated to have lucrative growth opportunities in the future with the rising demand for cancer/tumor profiling market in the global market. Below mentioned is the list of few companies engaged in the cancer/tumor profiling market.
The report also includes the profiles of key players in cancer/tumor profiling market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Illumina, Inc.
- QIAGEN N.V.
- NeoGenomics Laboratories, Inc.
- HTG Molecular Diagnostics, Inc.
- Genomic Health Inc.
- Caris Life Sciences
- Helomics Corporation
- NanoString Technologies, Inc.
- Sysmex Corporation
- Roche Diagnostics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Profiling Market - By Technology
1.3.2 Cancer Profiling Market - By Type
1.3.3 Cancer Profiling Market - By Application
1.3.4 Cancer Profiling Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CANCER PROFILING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CANCER PROFILING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CANCER PROFILING MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER PROFILING - GLOBAL MARKET OVERVIEW
6.2. CANCER PROFILING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. CANCER PROFILING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOASSAYS
7.3.1. Overview
7.3.2. Immunoassays Market Forecast and Analysis
7.4. HYBRIDIZATION
7.4.1. Overview
7.4.2. Hybridization Market Forecast and Analysis
7.5. SEQUENCING TECHNIQUES
7.5.1. Overview
7.5.2. Sequencing Techniques Market Forecast and Analysis
7.6. MASS SPECTROMETRY
7.6.1. Overview
7.6.2. Mass Spectrometry Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CANCER PROFILING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. LUNG CANCER
8.3.1. Overview
8.3.2. Lung Cancer Market Forecast and Analysis
8.4. BREAST CANCER
8.4.1. Overview
8.4.2. Breast Cancer Market Forecast and Analysis
8.5. COLORECTAL CANCER
8.5.1. Overview
8.5.2. Colorectal Cancer Market Forecast and Analysis
8.6. PROSTATE CANCER
8.6.1. Overview
8.6.2. Prostate Cancer Market Forecast and Analysis
8.7. MELANOMA CANCER
8.7.1. Overview
8.7.2. Melanoma Cancer Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. CANCER PROFILING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CLINICAL APPLICATION
9.3.1. Overview
9.3.2. Clinical Application Market Forecast and Analysis
9.4. RESEARCH APPLICATION
9.4.1. Overview
9.4.2. Research Application Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. others Market Forecast and Analysis
10. CANCER PROFILING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Cancer Profiling Market Overview
10.1.2 North America Cancer Profiling Market Forecasts and Analysis
10.1.3 North America Cancer Profiling Market Forecasts and Analysis - By Technology
10.1.4 North America Cancer Profiling Market Forecasts and Analysis - By Type
10.1.5 North America Cancer Profiling Market Forecasts and Analysis - By Application
10.1.6 North America Cancer Profiling Market Forecasts and Analysis - By Countries
10.1.6.1 United States Cancer Profiling Market
10.1.6.1.1 United States Cancer Profiling Market by Technology
10.1.6.1.2 United States Cancer Profiling Market by Type
10.1.6.1.3 United States Cancer Profiling Market by Application
10.1.6.2 Canada Cancer Profiling Market
10.1.6.2.1 Canada Cancer Profiling Market by Technology
10.1.6.2.2 Canada Cancer Profiling Market by Type
10.1.6.2.3 Canada Cancer Profiling Market by Application
10.1.6.3 Mexico Cancer Profiling Market
10.1.6.3.1 Mexico Cancer Profiling Market by Technology
10.1.6.3.2 Mexico Cancer Profiling Market by Type
10.1.6.3.3 Mexico Cancer Profiling Market by Application
10.2. EUROPE
10.2.1 Europe Cancer Profiling Market Overview
10.2.2 Europe Cancer Profiling Market Forecasts and Analysis
10.2.3 Europe Cancer Profiling Market Forecasts and Analysis - By Technology
10.2.4 Europe Cancer Profiling Market Forecasts and Analysis - By Type
10.2.5 Europe Cancer Profiling Market Forecasts and Analysis - By Application
10.2.6 Europe Cancer Profiling Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Cancer Profiling Market
10.2.6.1.1 Germany Cancer Profiling Market by Technology
10.2.6.1.2 Germany Cancer Profiling Market by Type
10.2.6.1.3 Germany Cancer Profiling Market by Application
10.2.6.2 France Cancer Profiling Market
10.2.6.2.1 France Cancer Profiling Market by Technology
10.2.6.2.2 France Cancer Profiling Market by Type
10.2.6.2.3 France Cancer Profiling Market by Application
10.2.6.3 Italy Cancer Profiling Market
10.2.6.3.1 Italy Cancer Profiling Market by Technology
10.2.6.3.2 Italy Cancer Profiling Market by Type
10.2.6.3.3 Italy Cancer Profiling Market by Application
10.2.6.4 Spain Cancer Profiling Market
10.2.6.4.1 Spain Cancer Profiling Market by Technology
10.2.6.4.2 Spain Cancer Profiling Market by Type
10.2.6.4.3 Spain Cancer Profiling Market by Application
10.2.6.5 United Kingdom Cancer Profiling Market
10.2.6.5.1 United Kingdom Cancer Profiling Market by Technology
10.2.6.5.2 United Kingdom Cancer Profiling Market by Type
10.2.6.5.3 United Kingdom Cancer Profiling Market by Application
10.2.6.6 Rest of Europe Cancer Profiling Market
10.2.6.6.1 Rest of Europe Cancer Profiling Market by Technology
10.2.6.6.2 Rest of Europe Cancer Profiling Market by Type
10.2.6.6.3 Rest of Europe Cancer Profiling Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Cancer Profiling Market Overview
10.3.2 Asia-Pacific Cancer Profiling Market Forecasts and Analysis
10.3.3 Asia-Pacific Cancer Profiling Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Cancer Profiling Market Forecasts and Analysis - By Type
10.3.5 Asia-Pacific Cancer Profiling Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Cancer Profiling Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Cancer Profiling Market
10.3.6.1.1 Australia Cancer Profiling Market by Technology
10.3.6.1.2 Australia Cancer Profiling Market by Type
10.3.6.1.3 Australia Cancer Profiling Market by Application
10.3.6.2 China Cancer Profiling Market
10.3.6.2.1 China Cancer Profiling Market by Technology
10.3.6.2.2 China Cancer Profiling Market by Type
10.3.6.2.3 China Cancer Profiling Market by Application
10.3.6.3 India Cancer Profiling Market
10.3.6.3.1 India Cancer Profiling Market by Technology
10.3.6.3.2 India Cancer Profiling Market by Type
10.3.6.3.3 India Cancer Profiling Market by Application
10.3.6.4 Japan Cancer Profiling Market
10.3.6.4.1 Japan Cancer Profiling Market by Technology
10.3.6.4.2 Japan Cancer Profiling Market by Type
10.3.6.4.3 Japan Cancer Profiling Market by Application
10.3.6.5 South Korea Cancer Profiling Market
10.3.6.5.1 South Korea Cancer Profiling Market by Technology
10.3.6.5.2 South Korea Cancer Profiling Market by Type
10.3.6.5.3 South Korea Cancer Profiling Market by Application
10.3.6.6 Rest of Asia-Pacific Cancer Profiling Market
10.3.6.6.1 Rest of Asia-Pacific Cancer Profiling Market by Technology
10.3.6.6.2 Rest of Asia-Pacific Cancer Profiling Market by Type
10.3.6.6.3 Rest of Asia-Pacific Cancer Profiling Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Cancer Profiling Market Overview
10.4.2 Middle East and Africa Cancer Profiling Market Forecasts and Analysis
10.4.3 Middle East and Africa Cancer Profiling Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Cancer Profiling Market Forecasts and Analysis - By Type
10.4.5 Middle East and Africa Cancer Profiling Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Cancer Profiling Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Cancer Profiling Market
10.4.6.1.1 South Africa Cancer Profiling Market by Technology
10.4.6.1.2 South Africa Cancer Profiling Market by Type
10.4.6.1.3 South Africa Cancer Profiling Market by Application
10.4.6.2 Saudi Arabia Cancer Profiling Market
10.4.6.2.1 Saudi Arabia Cancer Profiling Market by Technology
10.4.6.2.2 Saudi Arabia Cancer Profiling Market by Type
10.4.6.2.3 Saudi Arabia Cancer Profiling Market by Application
10.4.6.3 U.A.E Cancer Profiling Market
10.4.6.3.1 U.A.E Cancer Profiling Market by Technology
10.4.6.3.2 U.A.E Cancer Profiling Market by Type
10.4.6.3.3 U.A.E Cancer Profiling Market by Application
10.4.6.4 Rest of Middle East and Africa Cancer Profiling Market
10.4.6.4.1 Rest of Middle East and Africa Cancer Profiling Market by Technology
10.4.6.4.2 Rest of Middle East and Africa Cancer Profiling Market by Type
10.4.6.4.3 Rest of Middle East and Africa Cancer Profiling Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Cancer Profiling Market Overview
10.5.2 South and Central America Cancer Profiling Market Forecasts and Analysis
10.5.3 South and Central America Cancer Profiling Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Cancer Profiling Market Forecasts and Analysis - By Type
10.5.5 South and Central America Cancer Profiling Market Forecasts and Analysis - By Application
10.5.6 South and Central America Cancer Profiling Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Cancer Profiling Market
10.5.6.1.1 Brazil Cancer Profiling Market by Technology
10.5.6.1.2 Brazil Cancer Profiling Market by Type
10.5.6.1.3 Brazil Cancer Profiling Market by Application
10.5.6.2 Argentina Cancer Profiling Market
10.5.6.2.1 Argentina Cancer Profiling Market by Technology
10.5.6.2.2 Argentina Cancer Profiling Market by Type
10.5.6.2.3 Argentina Cancer Profiling Market by Application
10.5.6.3 Rest of South and Central America Cancer Profiling Market
10.5.6.3.1 Rest of South and Central America Cancer Profiling Market by Technology
10.5.6.3.2 Rest of South and Central America Cancer Profiling Market by Type
10.5.6.3.3 Rest of South and Central America Cancer Profiling Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CANCER PROFILING MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. CANCER PROFILING MARKET, KEY COMPANY PROFILES
13.1. ILLUMINA, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. QIAGEN N.V.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. NEOGENOMICS LABORATORIES, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. HTG MOLECULAR DIAGNOSTICS, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GENOMIC HEALTH INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. CARIS LIFE SCIENCES
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. HELOMICS CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. NANOSTRING TECHNOLOGIES, INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SYSMEX CORPORATION
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ROCHE DIAGNOSTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Illumina, Inc.
2. QIAGEN N.V.
3. NeoGenomics Laboratories, Inc.
4. HTG Molecular Diagnostics, Inc.
5. Genomic Health Inc.
6. Caris Life Sciences
7. Helomics Corporation
8. NanoString Technologies, Inc.
9. Sysmex Corporation
10. Roche Diagnostics
11. Hologic Gen-Probe
12. Siemens Healthineers
13. Personal Genome Diagnostics, Inc.
14. Perthera, Inc.
15. Contextual Genomics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For